We are live on ! Find out more
MBIO icon

Mustang Bio

92 hedge funds and large institutions have $85.7M invested in Mustang Bio in 2021 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 40 increasing their positions, 18 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

122% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 18

108% more call options, than puts

Call options by funds: $1.95M | Put options by funds: $938K

7% more capital invested

Capital invested by funds: $80.5M → $85.7M (+$5.25M)

0% more ownership

Funds ownership: 0.04%0.04% (+0%)

3% less funds holding

Funds holding: 9592 (-3)

20% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 15

Holders
92
Holders Change
-3
Holders Change %
-3.16%
% of All Funds
1.6%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
12
Increased
40
Reduced
18
Closed
15
Calls
$1.95M
Puts
$938K
Net Calls
+$1.01M
Net Calls Change
+$1.18M

MBIO Hedge Fund Activity: Q2 2021 in Review

92 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Mustang Bio (MBIO) for Q2 2021, worth a combined $85.7M — up 6.5% from $80.5M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of MBIO and 12 opened new positions — a net loss of 3 holders — while 18 trimmed existing stakes and 40 added.

The largest buyer was Vanguard Group, adding an estimated $4.94M. The largest seller was Jacobs Levy Equity Management, cutting an estimated $3.2M.

  • 92 institutional investors held Mustang Bio (MBIO) as of Q2 2021, down from 95 in Q1 2021.
  • Funds reported $85.7M of Mustang Bio stock for Q2 2021, up 6.5% quarter-over-quarter.
  • 12 funds opened new Mustang Bio positions in Q2 2021 and 15 closed out, a net change of -3 holders.
  • The largest Mustang Bio buyer in Q2 2021 was Vanguard Group, an estimated $4.94M added.
  • The largest Mustang Bio seller in Q2 2021 was Jacobs Levy Equity Management, an estimated $3.2M sold.

Based on aggregated 13F filings for Q2 2021.